26.01.2021 • NewsCorbion

Corbion Expands North American Lactic Acid

Dutch lactic acid specialist Corbion said it plans to increase its North American capacity by about 40% to meet growing demand for natural ingredients in multiple industries and reinforce its position as a leading worldwide supplier of lactic acid and derivatives.

The expansion will take place at the company’s US plant in Blair, Nebraska, USA. Corbion, which also produces lactic acid in the Netherlands, Brazil, Spain and Thailand, did not disclose capacity figures or a start-up date for the expanded capacity. In early 2020 it announced plans to expand its offering in Asia with a new plant at an existing site in Rayong Province, Thailand.

Corbion said it aims to achieve the US expansion at in the most sustainable way possible. Without giving details, it said it will employ technology designed to enable a significant boost in efficiency while avoiding an increase in emissions, thus demonstrating that production growth can be decoupled from CO2 output.

The use of lactic acid and its derivatives as ingredients in foods and beverages for safe preservation, and in home and personal care products for effective but gentle disinfection and hygiene, has increased steadily in the Americas over the past five years, the company said.  

Author: Dede Williams, Freelance Journalist

 

Dutch lactic acid specialist Corbion plans to increase North American output by...
Dutch lactic acid specialist Corbion plans to increase North American output by 40% to meet growing demand for natural ingredients and reinforce its position as a leading supplier worldwide. Capability will be added at Blair, Nebraska. No start-up date has been given. (c) Corbion

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.